Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Clinical trial NCT06465810 · RECRUITING

Trial details

NCT number: NCT06465810
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Transthyretin Amyloidosis ATTR-CM ATTRv-PN ATTR ATTR-Mixed hATTR

Start date: 2024-06-25
Primary completion: 2031-12-29
Enrollment: 1850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.